|
Vaishali Pharma Ltd.
|
Ratio Analysis
|
|
|
You can view the
Ratio Analysis
for the last 5 years.
|
Market Cap. (Rs.)
|
114.88 Cr.
|
P/BV
|
1.64
|
Book Value (Rs.)
|
5.19
|
|
52 Week High/Low (Rs.)
|
13/5
|
FV/ML
|
2/1
|
P/E(X)
|
27.59
|
|
Bookclosure
|
15/10/2024
|
EPS (Rs.)
|
0.31
|
Div Yield (%)
|
0.00
|
|
| Months | 12 |
| Source Of Info (AR = Annual Report, PR = Press Release) | PR |
| FaceValue | 2.00 |
| | |
| PER SHARE RATIOS | |
| | |
| Basic EPS (Rs.) | 0.32 |
| Diluted EPS (Rs.) | 0.32 |
| Cash EPS (Rs.) | 0.35 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 5.30 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 5.30 |
| Revenue From Operations / Share (Rs.) | 8.34 |
| PBDIT / Share (Rs.) | 0.60 |
| PBIT / Share (Rs.) | 0.56 |
| PBT / Share (Rs.) | 0.41 |
| Net Profit / Share (Rs.) | 0.30 |
| NP After MI And SOA / Share (Rs.) | 0.31 |
| | |
| PROFITABILITY RATIOS | |
| | |
| PBDIT Margin (%) | 7.30 |
| PBIT Margin (%) | 6.75 |
| PBT Margin (%) | 4.95 |
| Net Profit Margin (%) | 3.70 |
| NP After MI And SOA Margin (%) | 3.82 |
| Return on Networth / Equity (%) | 6.02 |
| Return on Capital Employeed (%) | 9.78 |
| Return On Assets (%) | 3.37 |
| Long Term Debt / Equity (X) | 0.08 |
| Total Debt / Equity (X) | 0.26 |
| | |
| LIQUIDITY RATIOS | |
| | |
| Current Ratio (X) | 2.34 |
| Quick Ratio (X) | 2.27 |
| | |
| COVERAGE RATIOS | |
| | |
| Interest Coverage Ratio (%) | 4.05 |
| Interest Coverage Ratio (Post Tax) (%) | 3.05 |
| | |
| VALUATION RATIOS | |
| | |
| Enterprise Value (Cr.) | 80.76 |
| EV / Net Operating Revenue (X) | 0.74 |
| EV / EBITDA (X) | 10.16 |
| MarketCap / Net Operating Revenue (X) | 0.58 |
| Price / BV (X) | 0.92 |
| Price / Net Operating Revenue (X) | 0.58 |
| EarningsYield | 0.06 |
